Nate Shanok, PhD

Nate’s core research aims include the following:

• Identifying biomarkers (through brain activity, cognitive, and blood sample analysis) that can distinguish between different psychiatric and neurological conditions. This knowledge will ultimately allow us to deliver customized and effective treatment options in a timely manner.
• Evaluating innovative treatment options such as transcranial magnetic stimulation, IV ketamine therapy, and neurofeedback for the treatment of major depressive disorder, anxiety disorders, obsessive compulsive disorder, and Alzheimer’s disease.
• Determining the extent that these treatment options can alter biomarkers of mental and physical health including brain activity patterns, inflammatory markers, and neurotrophin levels.
• Identifying the role that perceived purpose in life plays in the development of disease, and evaluating daily lifestyle strategies and treatment options for maximizing purpose.

Delray Center for Brain Science (DCBS):

Nate currently serves as the director of DCBS, a clinical and research center providing numerous outpatient services. These include brain activity analysis through quantitative EEG (QEEG), cognitive assessments, and brain-based therapies such as transcranial magnetic stimulation (TMS) and neurofeedback.

Through cutting-edge diagnostic tools and neuropsychiatric treatments, DCBS is revolutionizing mental health care. There are also numerous research projects occurring at the center.

Study 1: The Effects of Deep TMS on Brain Activity Measures

Study 2: The Efficacy of Combining TMS and Ketamine Treatments

Study 3: Determining Whether TMS and Ketamine can Increase “Purpose in Life”

Participants are completing the purpose-in-life (PIL) questionnaire at baseline, session 20, and post-treatment. We hope to publish results by October 2023.